New York City voters didn’t just elect a self-proclaimed democratic socialist mayor — they handed the keys to the transition team to someone whose regulatory philosophy has already reshaped Washington: former Federal Trade Commission (FTC) Chair Lina Khan. During her tenure, Khan oversaw what CNBC’s Jim Cramer called a “one Read more…
A broad coalition of free-market, taxpayer-advocacy, and constitutional-rights organizations—including The Market Institute—sent a letter to Speaker Mike Johnson urging swift passage of H.R. 4312, the Student Compensation and Opportunity through Rights and Endorsements (SCORE) Act. SCORE Act Letter – 12.1.25 At its core, the SCORE Act restores sanity to the Read more…
A new analysis presented at CTAD 2025 by researchers at the USC Schaeffer Center offers one of the clearest pictures yet of how early intervention could transform the fight against Alzheimer’s disease. The findings show that anti-amyloid therapies, when started sooner, can meaningfully extend independence, reduce caregiver burden, and even Read more…
Virginia Governor-elect Abigail Spanberger campaigned as a centrist fixated on one theme: affordability. Voters were told she would govern as a level-headed moderate, skeptical of ideological excesses and focused squarely on cost-of-living relief. But as Market Institute Senior Fellow Norm Singleton writes in RealClearMarkets, Spanberger’s record in Congress tells a Read more…
As the FTC develops its Strategic Plan for 2026–2030, the agency has a rare chance to reset after years of mission drift. But as Norm Singleton writes in RealClearMarkets, the draft plan released in October misses the mark—ignoring statutory requirements and failing to address the central problem: the continued influence Read more…
A common refrain from Trump supporters is that everything he is doing is “common sense.” And at some level, they’re right. Taking aggressive measures to lower crime, strengthen the economy, and fix broken markets like pharmaceuticals sounds like exactly what a president should do. But as Charles Sauer writes in Read more…
Populism has always had political appeal—and as recent elections show, it can win. But as Market Institute President Charles Sauer argues in RealClearHealth, some forms of populism trade long-term prosperity for short-term applause. “Populism makes sense as a political strategy – as we can see from Momdani’s win in NY, Read more…
California Governor Gavin Newsom, often floated as a potential 2028 presidential candidate, recently vetoed SB-771 — a bill that would have made social media platforms legally liable for “recklessly” allowing so-called hate speech to appear on their sites. As Charles Sauer writes, the measure “would hold social media companies liable Read more…
More than 7 million Americans are currently living with Alzheimer’s — a number on track to double by 2050. Families across the country are already grappling with the emotional strain and the soaring financial cost of caring for loved ones. As Charles Sauer highlights in Politibrawl, this crisis is not Read more…
One reason libertarians don’t trust the government is because so many well-intentioned programs end up either making things worse for the supposed beneficiaries, enriching powerful interests — or both. Norm Singleton highlights one such example: the federal Section 340B prescription drug program, which has quietly ballooned into a multi-billion-dollar market Read more…